News & Events
iCAD & ProFound Breast Health Suite in the News
Press Releases
iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024
NASHUA, N.H. – March 19, 2025 – iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the fourth quarter and full…
iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025
NASHUA, N.H., March 11, 2025 — iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the fourth quarter and year ended December 31, 2024, after market close, and host a conference call at 4:30 PM Eastern Time…
iCAD and RamSoft Announce Partnership to Deliver ProFound AI-Powered Mammography Solutions Across North America
NASHUA, NH, and TORONTO, CANADA, March 05, 2025 — iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and RamSoft®, a global leader in cloud-based RIS/PACS radiology solutions for imaging centers and providers, today announced a new strategic commercial preferred distributor and integration partnership across…
In the Media
Data-Driven Breast Care: Transforming the Future of Breast Cancer Detection and Care.
Radiology Today, March 2025
Koios Medical, iCAD Work to Expand AI-Powered Breast Cancer Detection
Imaging Technology News
Koios Medical, iCAD to collaborate on AI for breast cancer detection
Auntminnie.com
Upcoming Tradeshows & Meetings
2025 Baptist Health Women’s Cancer Symposium
Her breast health journey deserves trust and confidence—empower it with iCAD’s AI-powered solutions, offering faster, more precise insights to help you deliver exceptional care today—and tomorrow. With iCAD, reduce diagnostic uncertainty and ensure she gets the right care at the right time, giving her confidence and peace of mind.
2025 SBI Breast Imaging Symposium
Her breast health journey deserves trust and confidence—empower it with iCAD’s AI-powered solutions, offering faster, more precise insights to help you deliver exceptional care today—and tomorrow. With iCAD, reduce diagnostic uncertainty and ensure she gets the right care at the right time, giving her confidence and peace of mind.
Webinars
Case Review with ProFound AI Detection Solutions, Presented by Dr. Rafaele Vautrin, Radiologist at Imapole Lyon Villeurbanne
Dr. Vautrin, a user of iCAD’s ProFound AI solution for 2D and 3D mammography for nearly two years, shares her experience through a series of clinical cases where the AI-provided insights were crucial in detecting cancer in her patients.
Symposium JFR 2024
Apport des solutions d’intelligence artificielle d’iCAD pour un meilleur dépistage du cancer du sein détection, densité et risque : revue des dernières études cliniques et revue de cas. Présenté par Pr Bruno Boyer, CIMI, Paris
Revue de cas cliniques avec les solutions ProFound AI détection, présentés par le Dr Rafaele Vautrin, Radiologue à Imapole Lyon Villeurbanne.
Utilisatrice de la solution ProFound IA d’iCAD pour les mammographies 2D et 3D depuis près de deux ans, le Dr Vautrin partage son retour d’expérience au travers d’une dizaine de cas cliniques pour lesquels les informations fournies par l’IA se sont avérées déterminantes pour détecter des cancers chez ses patientes.
Contact Us
Together, we can create a world where cancer can’t hide.
Ready to experience how ProFound can save lives?